Suppressor deletion therapy. Selective elimination of T suppressor cells using a hematoporphyrin-conjugated monoclonal antibody.
Steele
J K
JK
University of British Columbia, Vancouver, Canada.
Liu
D
D
Stammers
A T
AT
Deal
H
H
Whitney
S
S
Levy
J G
JG
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002470:Cell Survival / Q000187:drug effects; D006415:Hematoporphyrins / Q000494:pharmacology / Q000627:therapeutic use*; D007167:Immunotherapy; D000922:Immunotoxins / Q000627:therapeutic use*; D007942:Leukemia, Experimental / Q000628:therapy*; D008212:Lymphocyte Depletion / Q000379:methods*; D051379:Mice; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*
D000911:Antibodies, Monoclonal; D006415:Hematoporphyrins; D000922:Immunotoxins